Pulmonary function testing (PFT) is an indispensable tool in the diagnosis, monitoring, and management of respiratory diseases. However, interpretation of PFT results can be complex due to the multitude of factors influencing lung function. This article aims to provide a comprehensive guide to aid healthcare professionals in interpreting these results effectively.
Spirometry is the most common PFT, measuring the volume and speed of air a patient can inhale and exhale. The key parameters are Forced Vital Capacity (FVC), Forced Expiratory Volume in 1 second (FEV1), and their ratio (FEV1/FVC). A reduced FEV1/FVC ratio indicates obstructive lung disease, while a reduced FVC with a normal FEV1/FVC ratio suggests restrictive lung disease.
Diffusing capacity of the lungs for carbon monoxide (DLCO) measures the ability of the lungs to transfer gas from inhaled air to the red blood cells. A decreased DLCO may indicate emphysema, pulmonary fibrosis, or pulmonary vascular disease.
Residual volume (RV), total lung capacity (TLC), and functional residual capacity (FRC) are important in diagnosing lung diseases. Increased RV and FRC suggest air trapping seen in obstructive diseases, while decreased TLC indicates restrictive diseases.
Assessing bronchodilator responsiveness helps differentiate between asthma and Chronic Obstructive Pulmonary Disease (COPD). An increase in FEV1 or FVC by 12% and 200ml after bronchodilator use is suggestive of asthma.
Interpreting PFTs is a complex task requiring understanding of various parameters and their implications. However, with a systematic approach, healthcare professionals can accurately diagnose and manage respiratory diseases. Continuous learning and experience are key to mastering this vital skill.
1.
A US health panel advises starting mammograms at age 40 rather than 50.
2.
TULSA Is Effective in Long-Term Prostate Cancer Control.
3.
J. Craig Venter, Who Won the Race to Sequence the Human Genome, Dies at 79
4.
In Sickle Cell Disease, Lovo-Cel is "Life-Changing, Transformative.".
5.
How Social Determinants of Health Are Linked to Outcomes in Multiple Myeloma
1.
Molecular Matching for Individualized Blood-Disorder Therapy
2.
Everything You Need To Know About Melanoma Choroid: Causes, Symptoms, and Treatment
3.
Drug Safety Surveillance of Long-Term Medication Effects in Cancer Survivorship
4.
HPV-Related Cervical Cancer: Advances in Screening, Preventiofn & Treatment
5.
Early Diagnosis of Lung Cancer Through Emerging Biomarkers
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Current Scenario of Cancer- The Incidence of Cancer in Men
2.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
3.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
4.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation